MedLumics

MedLumics SL, founded in Madrid in 2011, is a medical device company focused on the design and development of an optically guided radio-frequency ablation system for the treatment of Atrial Fibrillation. Its flagship product, AblaView®, allows the operator to directly assess both the positioning of the ablation catheter on the myocardium and the continuity and transmurality of the ablation.